A1 receptors self-regulate adenosine release in the striatum: Evidence of autoreceptor characteristics

Neuroscience

Volumn 171, Issue 4, 2010, Pages 1006-1015

  Cechova, S ^a   Elsobky, A M ^a   Venton, B J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

A1 receptor; Adenosine; Dopamine; Microelectrode; Stimulated release; Voltammetry

Indexed keywords

6 N CYCLOPENTYLADENOSINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; AUTORECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; HALOPERIDOL; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; BENZAZEPINE DERIVATIVE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; N(6) CYCLOPENTYLADENOSINE; N(6)-CYCLOPENTYLADENOSINE; XANTHINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE METABOLISM; ELECTROSTIMULATION; MALE; MICROELECTRODE; NEUROTRANSMISSION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT; ANALYSIS OF VARIANCE; ANIMAL; BIOLOGICAL MODEL; DRUG INTERACTION; ELECTROCHEMISTRY; ELECTRODE; METABOLISM; METHODOLOGY; NERVE TRACT; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; TIME; VENTRAL TEGMENTUM;

ADENOSINE; ADENOSINE A1 RECEPTOR AGONISTS; ADENOSINE A1 RECEPTOR ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; BENZAZEPINES; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; ELECTRIC STIMULATION; ELECTROCHEMISTRY; ELECTRODES, IMPLANTED; MALE; MODELS, BIOLOGICAL; NEURAL PATHWAYS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; SUBSTANTIA NIGRA; TIME FACTORS; VENTRAL TEGMENTAL AREA; XANTHINES;

EID: 78650169702     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.09.063     Document Type: Article

References (41)

1. Acquas E., Di C.G. Role of dopamine D1 receptors in the control of striatal acetylcholine release by endogenous dopamine. Neurol Sci 2001, 22:41-42.
2. Alexander S.P., Reddington M. The cellular localization of adenosine receptors in rat neostriatum. Neuroscience 1989, 28:645-651.
3. Ballarin M., Fredholm B.B., Ambrosio S., Mahy N. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand 1991, 142:97-103.
4. Borycz J., Pereira M.F., Melani A., Rodrigues R.J., Kofalvi A., Panlilio L., Pedata F., Goldberg S.R., Cunha R.A., Ferre S. Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments. J Neurochem 2007, 101:355-363.
5. Bourne J.A. SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS Drug Rev 2001, 7:399-414.
6. Calabresi P., Centonze D., Pisani A., Bernardi G. Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses. J Neurosci 1997, 17:4509-4516.
7. Cechova S., Venton B.J. Transient adenosine efflux in the rat caudate-putamen. J Neurochem 2008, 105:1253-1263.
8. Christofi F.L. Purinergic receptors and gastrointestinal secretomotor function. Purinergic Signalling 2008, 4:213-236.
9. Cunha R.A., Milusheva E., Vizi E.S., Ribeiro J.A., Sebastiao A.M. Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem 1994, 63:207-214.
10. Ewing A.G., Bigelow J.C., Wightman R.M. Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. Science 1983, 221:169-171.
11. Ferre S. An update on the mechanisms of the psychostimulant effects of caffeine. J Neurochem 2008, 105:1067-1079.
12. Ferre S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 1997, 20:482-487.
13. Flagmeyer I., Haas H.L., Stevens D.R. Adenosine A1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro. Brain Res 1997, 778:178-185.
14. Franco R., Lluis C., Canela E.I., Mallol J., Agnati L., Casado V., Ciruela F., Ferre S., Fuxe K. Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins. J Neural Transm 2007, 114:93-104.
15. Garris P.A., Budygin E.A., Phillips P.E.M., Venton B.J., Robinson D.L., Bergstrom B.P., Rebec G.V., Wightman R.M. A role for presynaptic mechanisms in the actions of nomifensine and haloperidol. Neuroscience 2003, 118:819-829.
16. Halassa M.M., Fellin T., Haydon P.G. Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 2009, 57:343-346.
17. Hamilton B.R., Smith D.O. Autoreceptor-mediated purinergic and cholinergic inhibition of motor nerve terminal calcium currents in the rat. J Physiol 1991, 432:327-341.
18. Heien M.L.A.V., Phillips P.E.M., Stuber G.D., Seipel A.T., Wightman R.M. Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst 2003, 128:1413-1419.
19. Karcz-Kubicha M., Antoniou K., Terasmaa A., Quarta D., Solinas M., Justinova Z., Pezzola A., Reggio R., Muller C.E., Fuxe K., Goldberg S.R., Popoli P., Ferre S. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 2003, 28:1281-1291.
20. Kimura M., Saitoh N., Takahashi T. Adenosine A(1) receptor-mediated presynaptic inhibition at the calyx of held of immature rats. J Physiol 2003, 553:415-426.
21. Kuzmin A., Johansson B., Gimenez L., Ogren S.O., Fredholm B.B. Combination of adenosine A(1) and A(2A) receptor blocking agents induces caffeine-like locomotor stimulation in mice. Eur Neuropsychopharmacol 2006, 16:129-136.
22. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 2001, 79:463-484.
23. Masino S.A., Dulla C.G. Adenosine, glutamate and pH: interactions and implications. Neurol Res 2005, 27:149-152.
24. Missale C., Nash S.R., Robinson S.W., Jaber M.J., Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 1998, 78:189-225.
25. Montague P.R., McClure S.M., Baldwin P.R., Phillips P.E., Budygin E.A., Stuber G.D., Kilpatrick M.R., Wightman R.M. Dynamic gain control of dopamine delivery in freely moving animals. J Neurosci 2004, 24:1754-1759.
26. Okada M., Mizuno K., Kaneko S. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in the rat striatum. Neurosci Lett 1996, 212:53-56.
27. O'Neill C., Nolan B.J., Macari A., O'Boyle K.M., O'Connor J.J. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors. Eur J Neurosci 2007, 26:3421-3428.
28. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic, New York, NY.
29. Pazzagli M., Corsi C., Fratti S., Pedata F., Pepeu G. Regulation of extracellular adenosine levels in the striatum of aging rats. Brain Res 1995, 684:103-106.
30. Prediger R.D.S., Batista L.C., Takahashi R.N. Adenosine A(1) receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice. Eur J Pharmacol 2004, 499:147-154.
31. Quarta D., Borycz J., Solinas M., Patkar K., Hockemeyer J., Ciruela F., Lluis C., Franco R., Woods A.S., Goldberg S.R., Ferre S. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-d-aspartate receptor stimulation. J Neurochem 2004, 91:873-880.
32. Sanford A.L., Morton S.W., Whitehouse K.L., Oara H.M., Lugo-Morales L.Z., Roberts J.G., Sombers L.A. Voltammetric detection of hydrogen peroxide at carbon-fiber microelectrodes. Anal Chem 2010, 82:5205-5210.
33. Schindler C.W., Karcz-Kubicha M., Thorndike E.B., Muller C.E., Tella S.R., Ferre S., Goldberg S.R. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Br J Pharmacol 2005, 144:642-650.
34. Shaham Y., Stewart J. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology (Berl) 1996, 125:385-391.
35. Strand A.M., Venton B.J. Flame etching enhances the sensitivity of carbon-fiber microelectrodes. Anal Chem 2008, 80:3708-3715.
36. Swamy B.E.K., Venton B.J. Susbsecond detection of physiological adenosine concentrations using fast-scan cyclic voltammetry. Anal Chem 2007, 79:744-750.
37. Venton B.J., Seipel A.T., Phillips P.E., Wetsel W.C., Gitler D., Greengard P., Augustine G.J., Wightman R.M. Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 2006, 26:3206-3209.
38. Wojcik W.J., Neff N.H. Location of adenosine release and adenosine-A2 receptors to rat striatal neurons. Life Sci 1983, 33:755-763.
39. Wood P.L., Kim H.S., Boyar W.C., Hutchison A. Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation. Neuropharmacology 1989, 28:21-25.
40. Xu W., Zhu J.P., Angulo J.A. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse 2005, 58:110-121.
41. Yawo H., Chuhma N. Preferential inhibition of omega-conotoxin-sensitive presynaptic Ca2+ channels by adenosine autoreceptors. Nature 1993, 365:256-258.